Tag: Cancer: Cervical
USPSTF Issues Draft Recommendation Statement for Cervical Cancer Screening
Screening recommended every three years with cervical cytology for women aged 21 to 29 years, every five years with hrHPV screening at age 30 to 65 years
2016 to 2021 Saw Drop in Cervical Cancer Mortality for Women Younger Than 25
Estimated 26 additional cervical cancer deaths would have been expected between 2016 and 2021 assuming trends continued
One-Dose HPV Vaccination Averts Similar Number of Cancers as Two Doses
Under most pessimistic scenario, one dose would avert fewer cervical cancer cases with difference of 3 percent over 100 years
Breast Cancer Screening Attendance Helps Boost Other Cancer Screenings
Findings seen for women offered self-sampling kits for overdue cancer screenings
2007 to 2020 Saw Continuous Decrease in Cervical Cancer in Younger Women
During same period, significant increase was seen in incidence of CIN3 among those aged 25 to 29 years
Tisotumab Vedotin Efficacious for Recurrent Cervical Cancer
Second- or third-line treatment yields significantly greater efficacy than chemotherapy, including longer overall survival
Survival Improves With Open Hysterectomy for Cervical Cancer
Lower rate of disease-free survival and overall survival seen for minimally invasive versus open hysterectomy
Past-Year Pap Testing Rates Were Lower in 2022 Than 2019
Unadjusted past-year testing rates were significantly lower among rural than urban residents in 2022
FDA Approves First Self-Test Collection Kit for HPV
AACR: At-Home HPV Testing Boosts Cervical Cancer Screening Participation
Combining self-sampling with phone-based patient navigation further increases screening participation
